Chunk #21 — Results

Source: A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies.
Embedded: yes

Text

There were no statistically significant differences amongst the placebo conditions in 7-day point-prevalence outcomes at 1 week, end of treatment (EOT) or 6-months post-quit. Therefore, for all subsequent analyses, the placebo conditions were combined into a unified placebo condition.